scholarly journals A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of single-entity, once-daily hydrocodone tablets in patients with uncontrolled moderate to severe chronic low back pain

2015 ◽  
Vol 16 (11) ◽  
pp. 1593-1606 ◽  
Author(s):  
Warren Wen ◽  
Steve Sitar ◽  
Shau Yu Lynch ◽  
Ellie He ◽  
Steven R Ripa
Keyword(s):  
Low Back Pain ◽  
Back Pain ◽  
Chronic Low Back Pain ◽  
Controlled Trial ◽  
Low Back ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Once Daily ◽  
Double Blind Placebo ◽  
Single Entity

scholarly journals Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety

Pain ◽  
2020 ◽  
Vol 161 (9) ◽  
pp. 2068-2078 ◽  
Author(s):  
John D. Markman ◽  
Robert B. Bolash ◽  
Timothy E. McAlindon ◽  
Alan J. Kivitz ◽  
Manuel Pombo-Suarez ◽  
...  
Keyword(s):  
Low Back Pain ◽  
Back Pain ◽  
Chronic Low Back Pain ◽  
Low Back ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document